GeneDx Holdings (WGS) EBITDA Margin Growth (3y) (2023 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 3,294.00 |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 20.00 |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 333.00 |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 4,867.00 |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 1,424.00 |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 941.00 |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 2,869.00 |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | 9,073.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9,073.00 |
| Mar 31, 2026 | 8,372.00 |
| Dec 31, 2025 | 51,779.00 |
| Sep 30, 2025 | 10,632.00 |
| Jun 30, 2025 | 45,842.00 |
| Mar 31, 2025 | 16,034.00 |
| Dec 31, 2024 | 20,952.00 |
| Sep 30, 2024 | 19,430.00 |
| Jun 30, 2024 | 8,166.00 |
| Mar 31, 2024 | 28,443.00 |
| Dec 31, 2023 | 15,085.00 |
| Sep 30, 2023 | 6,448.00 |
| Jun 30, 2023 | 750.00 |
| Mar 31, 2023 | -8,255.00 |